• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. Aluminium coordination complexes in copolymerization reactions of carbon dioxide and epoxides
  Nduka Ikpo,Jenna C. Flogeras,Francesca M. Kerton Dalton Trans., 2013,42, 8998-9006
• 3. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Comprehensive Analysis of 1-(propan-2-yl)piperidine-4-thiol (CAS No. 156757-18-5): Properties, Applications, and Industry Trends

1-(propan-2-yl)piperidine-4-thiol (CAS No. 156757-18-5) is a specialized organic compound gaining attention in pharmaceutical and chemical research due to its unique structural features. This molecule combines a piperidine ring with a thiol functional group and an isopropyl substituent, making it a versatile intermediate for synthetic applications. Researchers are increasingly exploring its potential in drug discovery, particularly for targeting neurological and metabolic disorders, aligning with current trends in precision medicine and small-molecule therapeutics.

The compound's molecular structure (C8H17NS) features a hydrogen-bond donor/acceptor configuration that enhances its binding affinity with biological targets. Recent studies highlight its role as a building block for heterocyclic compounds, especially in developing kinase inhibitors and GPCR modulators – two hot topics in AI-driven drug design platforms. Its lipophilicity (LogP ≈ 1.8) and polar surface area (42 ?2) make it particularly valuable for optimizing blood-brain barrier permeability, a key challenge in CNS drug development.

From a synthetic chemistry perspective, 156757-18-5 demonstrates remarkable stability under microwave-assisted organic synthesis (MAOS) conditions, a technique frequently searched by chemists for green chemistry applications. The thiol group allows selective click chemistry reactions, enabling efficient conjugation with biocompatible polymers – a methodology trending in drug delivery system research. Analytical characterization via LC-MS and NMR spectroscopy confirms its high purity (>98%), meeting stringent requirements for GMP-compliant synthesis.

Industrial applications of 1-(propan-2-yl)piperidine-4-thiol are expanding beyond pharmaceuticals. Material scientists are investigating its derivatives as ligands for catalysis in asymmetric synthesis, responding to growing demand for chiral auxiliaries. The compound's metal-chelating properties show promise in developing OLED materials, coinciding with increased searches for organic electronic components. Stability studies indicate excellent performance in ionic liquid media, suggesting potential in energy storage applications.

Quality control protocols for CAS 156757-18-5 emphasize HPLC purity analysis and residual solvent monitoring, addressing regulatory concerns in pharmaceutical excipient manufacturing. The compound's structure-activity relationship (SAR) data is being incorporated into machine learning algorithms for virtual screening – a cutting-edge approach frequently queried in computational chemistry forums. Proper storage recommendations include nitrogen atmosphere protection to maintain the thiol group's reactivity.

Emerging research directions explore 1-(propan-2-yl)piperidine-4-thiol derivatives as covalent inhibitors, capitalizing on the thiol-disulfide exchange mechanism. This aligns with industry interest in targeted protein degradation technologies like PROTACs. The compound's metabolic stability profile makes it particularly valuable for developing long-acting formulations, addressing a key need in chronic disease management. Recent patent analyses show growing IP activity around its prodrug derivatives.

Environmental and safety assessments confirm that 156757-18-5 exhibits favorable biodegradation potential under OECD 301 guidelines, responding to increasing searches for sustainable chemistry metrics. The compound's low ecotoxicity profile supports its inclusion in green chemistry toolkits. Scale-up processes have been optimized using continuous flow chemistry systems, a technology dominating process chemistry discussions. Analytical method development focuses on UHPLC-MS/MS techniques for trace-level detection.

Market analysts note rising demand for 1-(propan-2-yl)piperidine-4-thiol in contract research organizations (CROs), particularly for fragment-based drug discovery platforms. The compound's structural diversity enables efficient scaffold hopping – a strategy frequently searched in medicinal chemistry databases. Technical literature emphasizes its utility in parallel synthesis approaches for generating compound libraries. Current price trends reflect its growing importance as a high-value intermediate in specialty chemicals markets.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)